We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mechanism of New Antiviral Drug Class Identified Using "Magnetic Tweezers"

News   Oct 25, 2017 | Original story from Penn State

 
Mechanism of New Antiviral Drug Class Identified Using "Magnetic Tweezers"

Schematic of the 'magnetic tweezers' used to assay the activity of a virus RNA polymerase (PV RdRp) enzyme in the presence of antiviral drugs. Researchers can monitor hundreds of individual enzymes as they replicate a strand of RNA that is attached to a magnetic bead allowing them to gather data on the mechanism of action of antiviral drugs. Credit: Penn State

 
 
 

RELATED ARTICLES

Atomic Structures of Flu, Measles, Mumps and RSV Mapped

News

The 3D atomic structure of a key complex in paramyxoviruses, a family of viruses that includes mumps, human parainfluenza and respiratory syncytial virus (RSV), have been determined. This information could help design and development of antiviral drugs for these viruses as well as for coronavirus, which functions similarly to paramyxoviruses.

READ MORE

Drug Combo for Childhood Brain Tumors Shows Promise in Lab Models

News

Combining the experimental cancer drug TAK228 (sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas, according to findings using animal and cell models.

READ MORE

Mouse Study Proposals Promising Parkinson's Molecule

News

A promising molecule has offered hope for a new treatment that could stop or slow Parkinson's. Researchers have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson's, as well as protect the dopamine-producing brain cells from dying.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE